Environmental

NRSN provides no disclosed environmental metrics in the supplied data, leaving peer comparison limited and suggesting neither clear leadership nor clear lagging versus biotech peers.

Zero reported R&D intensity in the provided metrics weakens evidence of environmental process efficiency, but the absence of disclosure prevents a stronger negative relative assessment.

No disclosed emissions, energy, water, or waste data in the available inputs reduces visibility on regulatory exposure, while peers with reporting frameworks appear better positioned.

The lack of environmental disclosure limits assessment of transition risk management, yet this is a common early-stage-company gap rather than a clear structural disadvantage versus peers.

Social

The supplied data show no workforce, safety, or clinical-trial social metrics, so NRSN cannot be credited for stronger social transparency relative to reporting peers.

Zero stock-based compensation in the metrics may indicate lower dilution-related employee alignment concerns, but it does not establish superior labor practices versus peers.

No patient, product safety, or community-impact disclosures are provided, which constrains assessment of social risk management compared with more transparent healthcare peers.

Limited social disclosure keeps reputational and stakeholder-risk visibility below best-in-class peers, although the available evidence does not indicate a severe social controversy.

Governance

The negative debt-to-equity ratio and near-zero net debt suggest a light leverage profile, which can reduce creditor pressure relative to more levered peers.

Zero stock-based compensation in the provided metrics may indicate lower equity-dilution governance concerns than peers that rely heavily on compensation-based issuance.

However, the absence of board, audit, ownership, and control disclosures prevents a stronger governance score because peer-leading oversight cannot be verified.

Overall governance appears operationally simple but under-disclosed, leaving NRSN broadly in line with smaller peers rather than clearly stronger.

Overall Score

NRSN appears broadly average versus peers on ESG because limited disclosure offsets a relatively simple capital structure and no clear evidence of major ESG controversy.

Score Driver: Limited ESG Disclosure Across Environmental, Social, And Governance Dimensions